Immunogenicity and safety of the inactivated enterovirus 71 vaccine administered concomitantly with the measles-rubella vaccine in infants aged 8 months in China: A noninferiority randomized controlled trial
InfectologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- Vaccine
- Publicado em
- 24 jun 2022
- Citações
- 0
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Immunogenicity and safety of the inactivated enterovirus 71 vaccine administered concomitantly with the measles-rubella vaccine in infants aged 8 months in China: A noninferiority randomized controlled trial
Zhimei Zhao, Yuyi Liao, Yuan Li, Guorun Jiang, Zhuhang Huang, Huijuan Yang, Zhiqiang Ou, Qiongzhou Yin, Junhu Chen, Yan Deng et al.
Descritores MeSH
- Enterovirus A, Human
- Enterovirus
- Measles
- Rubella
- Infant
- Measles-Mumps-Rubella Vaccine
- Measles Vaccine
- Immunogenicity, Vaccine
- Antibodies, Viral
- Vaccines, Inactivated
Veja também
Estudos relacionados
- Immunogenicity and safety of an inactivated enterovirus 71 vaccine co-administered with measles-mumps-rubella vaccine and live-attenuated Japanese encephalitis vaccine: a phase 4, single-center, randomized controlled trial
- Comparative analysis of immunogenicity of Chinese MMR and MR vaccines following primary vaccination in infants in Gansu Province
- Immunogenicity and safety of a measles and rubella-containing vaccine at age 6 and 9 months in Bangladesh: an open-label, randomised trial
- Evaluation of the Safety and Immunogenicity of M-M-RII (Combination Measles-mumps-rubella Vaccine): Clinical Trials of Healthy Children and Adults Published Between 2010 and 2019